Instrumentation Monthly recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining how pharmaceutical labs are adapting to tighter impurity thresholds and faster development timelines.
Quality Digest recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining
Lab Manager recently featured Inorganic Ventures in the article, "Trace-Level Testing, Validation Pressure, and the New Demands on Pharma Labs," examining how pharmaceutical labs are adapting to tighter impurity thresholds
As part of a planned leadership change at IV Labs of Christiansburg, Virginia, Brian Alexander, Ph.D., has been named president of its subsidiary, Inorganic Ventures. The specialty chemical company is a leading manufacturer of certified reference materials (CRM) and analytical inorganic standards trusted by laboratories worldwide.
He succeeds Christopher Gaines, who served as president of Inorganic Ventures and CEO of IV Labs. Gaines moves to board chair, and Justin Yalung has been named CEO of IV Labs.
Alexander, a geochemist, has served as the company's chief technical officer since 2020 and previously as vice president of technical operations. He brings more than a decade of deep scientific leadership to his new role. His promotion reflects Inorganic Ventures' commitment to science-driven growth and its ambition to strengthen its position as the partner of choice for analytical laboratories and manufacturers across the globe.
“Brian’s journey at Inorganic Ven
Gaines moves to board chair, Miller to vice chair, Alexander to president of Inorganic Ventures.
IV Labs, a Christiansburg-based specialty chemistry company serving manufacturers and laboratories worldwide, has appointed Justin Yalung as chief executive officer, and restructured its board of directors to reflect this change, effective June 1.
IV Labs is the parent company of Inorganic Ventures and PURE Laboratories. Together, the companies offer more than 2,000 stock elemental mixtures and compounds and more than 60,000 unique custom formulations. IV Labs products are used for critical production applications, research, testing, and calibration across sectors including pharmaceuticals, energy, environmental safety, mining, industrial manufacturing, and food & beverage.
“At IV Labs, we consider ourselves the quiet force for manufacturers across industries to deliver consistent, high-quality products with confidence,” Yalung said.
The United States Pharmacopeial Convention (USP) is a nonprofit organization focused on building trust in the quality of medicines, dietary supplements, and foods worldwide. Among its many analytical standards, USP General Chapter ⟨791⟩ pH establishes the mandatory potentiometric method for measuring the pH of pharmaceutical articles, providing a standardized framework laboratories must follow to produce reliable and reproducible res
USP General Chapter ⟨541⟩ Titrimetry establishes the foundational principles and standardized procedures for titrimetric analyses used in compendial pharmaceutical testing. This chapter defines titrimetry as a quantitative analytical technique in which a standardized reagent, known as the titrant, reacts stoichiometrically with an analyte until a reliable endpoint is reached, detected either visually or instrumentally.
Quality Digest recently featured Inorganic Ventures in the article, “Beyond the Pit: Why Laboratory Integrity Now Shapes Mining Viability,” highlighting the growing role analytical accuracy plays in the future of mining operations.
The article examines how mining companies are operating under increasingly narrow economic margins as lower-grade deposits and complex rare earth materials become more common. In these environments, analytical data is no longer just a supporting fun
Global Mining Review recently featured Inorganic Ventures in the article, “Beyond the Pit: Why Laboratory Integrity Now Shapes Mining Viability,” highlighting the growing importance of analytical precision in modern mining operations. (
Elemental impurities in pharmaceutical products are not a theoretical concern—they are a patient safety issue with well-documented toxicological consequences. The United States Pharmacopeia (USP) classifies arsenic (As), cadmium (Cd), lead (Pb), and mercury (Hg) as Class 1 elements, often referred to as the “Big Four.” These four elements are considered the highest-priority impurities because of their toxicity, prevalence in nature, and potential to contaminate raw materials, excipients, and finished drug products.
